Insider · CIK 0001652797

Schaffer Paul W.

Reports to the SEC for 1 company · WACONIA, MN

sec.gov

Transactions

Companies

Filings

CIK

0001652797

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-05-25	Panbela Therapeutics, Inc.A Award	Director	AAward	+4,316 sh	—	—	166,671
2021-05-25	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,368
2020-12-01	Panbela Therapeutics, Inc.A Award	Director	AAward	+2,875 sh	—	—	162,295
2020-09-08	Panbela Therapeutics, Inc.P Purchase	Director	PPurchase	+225 sh	$2.55	+$573.75	159,420
2020-09-04	Panbela Therapeutics, Inc.P Purchase	Director	PPurchase	+24.8K sh	$2.51	+$62.2K	159,195
2020-06-24	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+13.7K sh	—	—	13,700
2020-06-05	Panbela Therapeutics, Inc.P Purchase	Director	PPurchase	+10K sh	—	—	134,420
2020-06-05	Panbela Therapeutics, Inc.Warrant (right to buy)P Purchase	Director	PPurchase	+10K sh	—	—	10,000
2019-09-20	Panbela Therapeutics, Inc.P Purchase	Director	PPurchase	+30K sh	—	—	124,420
2019-09-20	Panbela Therapeutics, Inc.Warrants (right to buy)P Purchase	Director	PPurchase	+30K sh	—	—	30,000
2019-05-21	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+27K sh	—	—	27,000
2019-05-21	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,800 sh	—	—	6,800
2018-05-16	Panbela Therapeutics, Inc.P Purchase	Director	PPurchase	+2,000 sh	—	—	94,420
2018-05-16	Panbela Therapeutics, Inc.C Conversion	Director	CConversion	+11.8K sh	—	—	30,665
2018-05-16	Panbela Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	—	—	899,204
2018-05-16	Panbela Therapeutics, Inc.C Conversion	Director	CConversion	+11.8K sh	—	—	200,848
2018-05-16	Panbela Therapeutics, Inc.Warrant (right to buy)P Purchase	Director	PPurchase	+5,000 sh	—	—	5,000
2018-05-16	Panbela Therapeutics, Inc.Convertible Promissory NoteC Conversion	Director	CConversion	−50K sh	$50000.00	−$2.5B	0
2018-05-16	Panbela Therapeutics, Inc.Warrant (right to buy)C Conversion	Director	CConversion	+11.8K sh	—	—	11,756
2017-03-17	Panbela Therapeutics, Inc.Convertible Promissory NoteA Award	Director	AAward	+50K sh	$50000.00	+$2.5B	50,000
2016-12-12	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+208K sh	—	—	208,000
2016-12-12	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+160K sh	—	—	160,000
2016-06-24	Panbela Therapeutics, Inc.P Purchase	Director	PPurchase	+100K sh	—	—	189,092
2016-06-24	Panbela Therapeutics, Inc.Warrant (right to buy)P Purchase	Director	PPurchase	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
May 274
Schaffer Paul W.0001437749-21-013592
SEC(opens sec.gov)
Dec 34
Schaffer Paul W.0001437749-20-024772
SEC(opens sec.gov)
Sep 94
Schaffer Paul W.0001437749-20-019524
SEC(opens sec.gov)
Jun 264
Schaffer Paul W.0001437749-20-014004
SEC(opens sec.gov)
Jun 94
Schaffer Paul W.0001437749-20-012772
SEC(opens sec.gov)
Sep 244
Schaffer Paul W.0001437749-19-018986
SEC(opens sec.gov)
Sep 244/A
Schaffer Paul W.0001437749-19-018984
SEC(opens sec.gov)
May 234
Schaffer Paul W.0001437749-19-010781
SEC(opens sec.gov)
Jun 144
Schaffer Paul W.0001437749-18-011846
SEC(opens sec.gov)
Mar 214
Sun BioPharma, Inc.0001437749-17-005017
SEC(opens sec.gov)

Companies

Panbela Therapeutics, Inc.Director

Address

712 VISTA BLVD #305

WACONIA, MN, 55387